Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) EBITDA Margin (2020 - 2025)

Bio Essence (BIOE) has 6 years of EBITDA Margin data on record, last reported at 10.42% in Q3 2025.

  • For Q3 2025, EBITDA Margin rose 11915.0% year-over-year to 10.42%; the TTM value through Sep 2025 reached 30.54%, up 28447.0%, while the annual FY2024 figure was 141.83%, 7917.0% down from the prior year.
  • EBITDA Margin reached 10.42% in Q3 2025 per BIOE's latest filing, down from 23.63% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 23.63% in Q2 2025 and bottomed at 924.3% in Q1 2025.
  • Average EBITDA Margin over 5 years is 130.91%, with a median of 85.0% recorded in 2021.
  • The widest YoY moves for EBITDA Margin: up 41939bps in 2025, down -82562bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 93.3% in 2021, then skyrocketed by 59bps to 38.64% in 2022, then rose by 13bps to 33.66% in 2023, then plummeted by -81bps to 61.05% in 2024, then surged by 117bps to 10.42% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 10.42% in Q3 2025, 23.63% in Q2 2025, and 924.3% in Q1 2025.